---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-016176"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2022-06-29T23:59:59+00:00"
generated_at: "2026-06-24T22:19:24.803124+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DiaMedica Therapeutics subsidiary enters office lease for new headquarters in Minnetonka, MN

## Summary
- Lease for approx 6,175 sq ft at 301 Carlson Parkway, Suite 210, Minnetonka, MN.
- Initial term 5 years 5 months starting Sept 1, 2022, with option to extend 5 years.
- Rent approx $9,000/month after 5-month abatement, plus share of operating expenses and taxes.
- Company to relocate principal executive offices and R&D operations from current Plymouth location.
- Parent company DiaMedica Therapeutics provides lease guaranty; security deposit $8,750.

## SEC filing metadata
- accession: 0001437749-22-016176
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2022-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774922016176/0001437749-22-016176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774922016176/dmtp20220623_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-016176
- JSON: https://secwatch.observer/filing/0001437749-22-016176.json
- Plain text: https://secwatch.observer/filing/0001437749-22-016176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.